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SUMMARY
Direct lineage reprogramming induces dramatic
shifts in cellular identity, employing poorly under-
stood mechanisms. Recently, we demonstrated that
expression of Neurog2 or Ascl1 in postnatal mouse
astrocytes generates glutamatergic or GABAergic
neurons. Here, we take advantage of this model to
study dynamics of neuronal cell fate acquisition at
the transcriptional level. We found that Neurog2 and
Ascl1 rapidly elicited distinct neurogenic programs
with only a small subset of shared target genes.
Within this subset, only NeuroD4 could by itself
induce neuronal reprogramming in both mouse and
human astrocytes, while co-expression with Insm1
was required for glutamatergic maturation. Cultured
astrocytes gradually became refractory to reprog-
ramming, in part by the repressor REST preventing
Neurog2 from binding to the NeuroD4 promoter.
Notably, in astrocytes refractory to Neurog2 activa-
tion, the underlying neurogenic program remained
amenable to reprogrammingbyexogenousNeuroD4.
Our findings support a model of temporal hierarchy
for cell fate change during neuronal reprogramming.
INTRODUCTION
During development, neuronal subtypes are generated typically
in distinct regions with patterning cues initiating regional pro-
grams of neurogenesis (Martynoga et al., 2012). In the telen-
cephalon, for example, stem and progenitor cells in the ventral
region are instructed to express the transcription factors Ascl1,
Gsx1/2, and Dlx1/2, which then regulate the specification of
GABAergic projection and interneurons (for review see Imayoshi
and Kageyama, 2014); in the dorsal telencephalon, progenitors
express different transcription factors, such as Emx1/2, Pax6,
and Neurog1/2, which regulate the specification of glutamater-
gic projection neurons (Schuurmans and Guillemot, 2002). Anal-
ysis of the transcriptional programs in mouse mutants revealed
rather distinct transcriptional targets regulated by these tran-
scription factors in the dorsal and ventral telencephalon (Gohlke
et al., 2008). Whether this limited overlap is due to early diver-
gence of these regions initiated by patterning signals, resulting
in distinct transcriptional contexts, remains an open question.
Neurons may be specified in a hierarchical manner, with the
induction of common neuronal traits first, followed later by
neuronal subtype features via a final set of transcription factors,
such as terminal selector genes (Hobert, 2011). Conversely,
distinct transcriptional regulators may specify different neuronal
subtypes already at the onset of neuronal commitment, with rela-
tively little overlap between transcriptional programs.
Direct reprogramming is especially well suited to examine
the programs elicited by distinct transcription factors within the
same cellular and epigenetic context. When expressed in astro-
cytes obtained from postnatal murine cerebral cortex gray mat-
ter, Ascl1 instructsGABAergic neurons,whileNeurog2elicits glu-
tamatergic neurons (Berninger et al., 2007; Heinrich et al., 2010),
thusmaking possible the identification of target genes involved in
neuronal subtype specification within the same transcriptional
background. In different cell types, such as fibroblasts, Ascl1 in-
duces a glutamatergic neuronal fate in combination with Myt1L
74 Cell Stem Cell 17, 74–88, July 2, 2015 ª2015 The Authors
and Brn2 in fibroblasts (Vierbuchen et al., 2010), while Neurog2
forces motor neuron generation in combination with forskolin
and dorsomorphin (Liu et al., 2013). Thus, the cell of origin, with
its specific epigenetic landscape, can play a role in defining the
spectrum of reprogramming possibilities.
To date, the transcriptional programs elicited by direct line-
age conversion toward neuronal fates are still largely elusive.
Emerging evidences suggest an important role for epigenetic
mechanisms as a hurdle to reprogramming (Wapinski et al.,
2013; Xue et al., 2013). Large repressive protein complexes
have been implicated in cell fate specification and differentiation:
for instance, the REST/CoREST complex, known for its role in
maintaining neural stem cells (Laugesen and Helin, 2014) and
neuronal differentiation (Lu et al., 2014) has been shown to be
the target of miRNA-mediated reprogramming of fibroblast into
neurons (Xue et al., 2013). However, is it known neither when
and how REST contributes to repress direct reprogramming,
nor themechanisms relevant in establishing reprogramming bor-
ders during cell differentiation.
To tackle these important questions, we examined the tem-
poral regulation of genes at early stages of in vitro direct reprog-
ramming of young postnatal astrocytes into neurons using
tamoxifen-inducible forms of Ascl1 and Neurog2, which allowed
the unraveling of the dynamics of transcriptional regulation as
well as an understanding of the mechanisms involved in the fail-
ure to activate key targets in unresponsive astrocytes.
RESULTS
Activation of Neurog2ERT2 and Ascl1ERT2 Instructs
Neurons from Glia
In order to investigate the early events of direct reprogramming,
the cDNA ofNeurog2 and Ascl1was fused to themodified estro-
gen receptor ligand binding domain ERT2 (Raposo et al., 2015)
and sub-cloned into a retroviral construct, together with the
red fluorescent protein (DsRed-Expressed2, hereafter indicated
as DsRed) (Berninger et al., 2007; Heinrich et al., 2010; Heins
et al., 2002). Proliferating astrocytes were obtained from post-
natal day (P)6–7 mouse cerebral cortex Gray Matter (GM), avoid-
ing the White Matter (WM) and ventricular regions comprising
endogenous neural stem cells (Imura et al., 2006). The purity of
these cultures was previously assessed with various astrocytic
markers and genetic fate mapping (Berninger et al., 2007; Hein-
rich et al., 2010; Heins et al., 2002) (see also Figures S1I and S1J).
Moreover, cells infected with control retroviral vectors express-
ing GFP or DsRed showed a low proportion of Lewis X+ progen-
itors (3.9% ± 1.6% at day 2, Figures S1A–S1H) and did not
generate any bIII-tubulin+ neurons (0%, 250 cells counted/
experiment, n = 8). Likewise, Neurog2ERT2-transduced or
Ascl1ERT2-transduced cells remained GFAP+ and generated
virtually no neurons after 1 week without 4-hydroxy-tamoxifen
(OHT) addition (Figures 1B and 1E; quantification in Figures 1D
and 1G, 0% with Neurog2ERT2 and 0.8% with Ascl1ERT2;
Figures 1D and 1G). Thus, these cultures contain largely non-
neurogenic proliferating astrocytes.
Treatment with OHT for 4 consecutive days elicited the highest
efficiency of neuronal conversion, as assessed by morphology
and bIII-tubulin immunostaining (Figures 1C and 1F; quantifica-
tion in Figures 1D and 1G; for shorter periods see Figures
S1K–S1M). Importantly, this OHT treatment of Neurog2ERT2-
and Ascl1ERT2-transduced astroglia triggered similar reprog-
ramming efficiency (40% of DsRed+ cells), thus providing a
suitable system for the investigation of the transcriptional
changes during reprogramming triggered by the two factors.
Ascl1 and Neurog2 Induce Rapid but Distinct
Transcriptional Programs in Astrocytes In Vitro
First, we analyzed the transcriptome of Neurog2ERT2- and
Ascl1ERT2-transduced astroglial cultures after OHT-treatment
for 4, 24, and 48 hr (Figure 1H; Figures S1N and S1O0 for trans-
duction efficiency). Activation of Neurog2ERT2 for 4 hr changed
the expression of 199 probesets (fold change > 1.2, rawp (p value
of the t-test statistics) < 0.01, Table S1), suggesting that tran-
scriptional changes take place rapidly. This set of regulated
genes was significantly enriched for the gene ontology (GO)
terms (Huang et al., 2009) (as codified according to DAVID;
http://david.abcc.ncifcrf.gov) associated with ‘‘regulation of
cell proliferation,’’ ‘‘cell adhesion,’’ and, despite the early stage,
‘‘voltage-gated channel activity,’’ including genes expressed by
excitable cells, such as Scn8a and Cacna1d (Table S2). At 24 hr,
the number of Neurog2ERT2-regulated probesets increased
further by 27% (253, fold change > 1.2, rawp < 0.01, Figure S1P,
Table S1). At 48 hr a different group of probesets was regulated
(Figure S1P, Table S1), such that only 6% of the 712 probesets
regulated during the period analyzed showed an altered expres-
sion at two or more time points (43 probesets, Figure S1P). Thus,
large-scale and dynamic changes in gene expression take place
throughout the first 48 hr of direct neuronal reprogramming.
We then examined the transcriptome changes upon
Ascl1ERT2 activation, which resulted in a higher number of
regulated genes, possibly due to Ascl1 acting as a master and
pioneering transcription factor (Wapinski et al., 2013). Rapid
changes in gene expression were observed already at 4 hr
(621 probesets, GO terms in Table S4), increased at 24 hr
(1,148 probesets), and decreased at 48 hr (591 probesets; fold
change > 1.2, rawp < 0.01, Figure S1P0, Table S3). Overall,
13.5% of all the probesets altered at any time point after
Ascl1ERT2 activation were significantly regulated at two time
points at least (319 out of 2,360 probesets, Figure S1P0, Table
S3). Thus, Ascl1ERT2 also induced fast and dynamic changes
in gene expression, suggesting a rapid change in cellular
identity.
Of the probesets regulated by Neurog2ERT2 or Ascl1ERT2,
only 1.34% was common to both factors at 4 hr after induction
(Figure S1Q), 3.5% at 24 hr (Figures 1I and 1J), and 3.1% at
48 hr (Figure S1R). Overall, the probesets regulated by both
transcription factors account for only 2.8% of all the probesets
regulated at any time by either factor, demonstrating that the
small overlap is not due to different kinetics of the Neurog2-
and Ascl1-induced programs, but rather to the activation of
largely different gene cascades.
GO terms associated with the small subset of targets common
at 24 hr (49 probesets) were enriched for the terms ‘‘neuronal
development’’ and ‘‘neurogenesis’’ (Figure S1S, Table S5) with
79% of them expressed in neurons and progenitors throughout
the brain and 61% with a pan-neuronal expression (such as
Atoh8,Hes6, Insm1,NeuroD4, Prox1, Sox11, and Trnp1; see Ta-
ble S6). Selected candidates downstream of Neurog2ERT2 and
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Figure 1. Temporal Analysis of Genome-wide Transcription Changes in Astrocyte Reprogramming
(A) Schematic representation of the experimental procedure inducing the activation of Neurog2ERT2-IRES-DsRed or Ascl1ERT2-IRES-DsRed by tamoxifen
(OHT indicated by uppermost black bars) for reprogramming astrocytes into neurons.
(legend continued on next page)
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Ascl1ERT2were validated by real-time qPCRat 24 hr (Figures 1K
and 1L). The expression of Dlx2, a known target of Ascl1 (Poitras
et al., 2007), was unaffected by Neurog2ERT2 (Figure 1K), and
expression of Phf6, a Neurog2-regulated gene (Voss et al.,
2007), was reduced after Ascl1ERT2 activation (Figure 1L), con-
firming that the overexpression of these factors in astrocytes did
not affect their target specificity.
Identification of Target Genes Crucial for the
Reprogramming of Astroglial Cells
To examine the contribution of the common downstream targets
during reprogramming, we designed miRNAs against a subset of
these candidates (most efficient in red; Figure S2). While astro-
cytes transduced with a construct co-expressing Neurog2 and
a miRNA-scramble control gave rise to a substantial number
of bIII-tubulin+ neurons (Figures 2A and 2B–2B0 0 0), much fewer
neurons were generated upon a specific miRNA’s co-expression
(Figures 2C–2C0 0 0; example with miRNA-NeuroD4). All Neurog2-
IRES-miRNA constructs except for Neurog2-IRES-miRNA-
Trnp1 reduced the proportion of neurons among infected cells
to almost 50% or less compared to Neurog2-miRNA-scamble
control (Figure2D). ThepercentageofGFAP+cells didnotchange
significantly between gene-specific and scramble-miRNAs (Fig-
ure 2D) with the exceptions of miRNA-Hes6 and miRNA-Prox1.
Upon knockdown of Hes6, Insm1, and NeuroD4, the proportion
of GFAP-bIII-tubulin double negative cells increased among
GFP-labeled cells (Figure 2D), suggesting that some transduced
cells might have undergone partial reprogramming.
(B, C, E, and F) Micrographs of astrocytes infected with the constructs indicated in red on the left side and immunostained for the astrocytic marker GFAP (green)
and the neuronal marker bIII-tubulin (white). Scale bars, 100 mm.
(D and G) Quantification of non-reprogrammed cells (GFAP) or reprogrammed cells (bIII-tubulin) without or with OHT 8 days post-induction (DPI). Mean ± SEM;
n = 4 independent experiments; statistical test: two-tailed Mann-Whitney test (*p < 0.05).
(H) Schematic representation of the experimental procedure for genome-wide mRNA analysis.
(I) Heatmap of genes regulated by both Neurog2ERT2 and Ascl1ERT2 within 24 hr after induction by OHT.
(J) Venn diagram of genes regulated by Neurog2ERT2 or Ascl1ERT2 24 hr after OHT.
(K and L) Real-time qPCR) analysis on selected candidates upon Neurog2ERT2 (K) or Ascl1ERT2 (L) induction by OHT for 24 hr. Mean ± SEM; n = 3 independent
experiments.
See also Figure S1, Table S1, Table S2, Table S3, Table S4, and Table S5.
Figure 2. Identification of Essential Downstream Effectors in Astrocyte Reprogramming
(A) Schematic representation of retrovirus with expression cassette for miRNAs.
(B, C, E, and F) Micrographs of astrocytes, infected with the vectors indicated on top of the panels (green), were immunostained for GFAP (red) and bIII-tubulin
(white). Scale bars, 50 mm.
(D and G) Quantification of changes in bIII-tubulin+ neurons (gray bars), GFAP+ astrocytes (blue bars) or double-negative cells (red bars) at 8 DPI with the vectors
indicated on top of the histograms. Mean ± SEM in (D); n = 4 independent experiments (*p < 0.05; **p < 0.01). Mean ± SEM in (G); n = 3 independent experiments
(*p < 0.05).
See also Figure S2.
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Consistent with the selected factors acting also downstream
of Ascl1, miRNAs against Insm1, NeuroD4, and Prox1 reduced
the proportion of neurons induced by Ascl1 in astrocytic cultures
to 20% or less of the proportion of neurons found in Ascl1-
miRNA-scrambled-transduced cultures and to 50% or less for
Hes6, Sox11, and Trnp1 (Figures 2E–2E0 0 0 and F–F0 0 0, quantifica-
tion in Figure 2G). Little increase in GFAP+ or double negative
cells was observed in cultures transduced with Ascl1-specific
miRNA viruses (Figures 2E and 2G). Thus, Ascl1 represses the
astrocyte fate independently of the selected neurogenic targets,
in contrast to Neurog2 (Figure 2D).
Together these data indicate that few commonly regulated
neurogenic transcription factors are essential contributors to
the reprogramming process.
Direct Neuronal Reprogramming by
Downstream Effectors
To test whether the selected downstream transcription factors
could elicit neuronal reprogramming on their own, we combined
the expression of three genes at time and found NeuroD4 (ND4)
present in all of the pools inducing neurons at 8 days post-trans-
duction (DPT) (Figure S3A). Moreover, ND4 alone was sufficient
to induce a small but consistent fraction of bIII-tubulin+ neuronal
cells (1%–3%, Figures 3A and 3F), while none of the other factors
succeeded in doing so (data not shown). With the combination
of two factors, ND4 was most efficient in eliciting neuronal
conversion with Insm1 (I), Prox1 (P), or Sox11 (S11) (Figures
3C–3F). Reprogrammed cells showed a distinct neuronal
morphology with elaborated dendrites and a long thin process,
reminiscent of an axon (Figures 3B–3E). ND4-induced neurons
had more branched neurites than NeuroD4-Insm1-induced neu-
rons (ND4+I), suggesting that these might be distinct neuronal
subtypes (Figure 3G).
To determine whether reprogrammed neuronal cells acquired
a genuine neuronal identity, cells transduced with the most
efficient combinations of target genes (ND4+I, ND4+P, and
ND4 as control; Figures 4B–4D) were analyzed by patch-clamp
recording at 28–35 DPI after a 2-week co-culture with cells
derived from cerebral cortex at embryonic day (E)14.5 (Fig-
ure 4A). All cells with neuronal morphology recorded upon ND4
expression (17/17, Figure 4B, n = 5 independent experiments)
or ND4+I (11/11, Figure 4C, n = 3) generated action potentials
(APs) upon receiving an injection of suprathreshold current
pulses, whereas only 45.5% (5/11, Figure 4D, n = 2) of ND4+P
Figure 3. Combinations of Common Downstream Targets Reprogram Astrocytes into Neurons
(A) Schematic representation of the experimental procedure.
(B–E) Micrographs depicting astrocytes co-infected with the constructs indicated on top of the panels (red and green) immunostained for bIII-tubulin (white) at
8 DPI. Scale bars, 50 mm.
(F) Quantification of bIII-tubulin+ cells with neuronal morphology among DsRed+GFP+ double infected cells at 8 DPI. Mean ± SEM; n = 4 independent exper-
iments (*p < 0.05).
(G) Quantification of branches per neurons/combination. Mean ± SEM; n = 3 independent experiments (**p < 0.01).
See also Figures S3 and S4.
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co-transduced neurons fired an AP. Analysis of neuronal proper-
ties, such as resting membrane potential, input resistance, so-
matic membrane time constant, AP threshold, and mean AP
amplitude (summarized in Figure 4E) confirmed the functional
neuronal nature of reprogrammed cells. ND4-transduced neu-
rons responded to injection of suprathreshold current pulses
(1 s) with repetitive spike discharges (example in Figure 4B0 0 0)
associatedwith frequency adaptation in 72%of cases (8/11, Fig-
ures 4B0 0 and 4B0 0 0), as did ND4+I neurons (6/6; example in Fig-
ure 4C0 0 and 4C0 0 0) and ND4+P neurons (5/5, Figures 4D0 0 and
4D0 0 0; for higher variability see pie chart in Figure 4D0 0 0). Interest-
ingly, this pattern resembles that of regular spiking neurons re-
corded in acute slices of the cerebral cortex (Zolles et al., 2009).
As proof of principle, ND4-reprogrammed neurons were
recorded during pharmacological treatments: for instance,
addition of TTX (0.5 mM, n = 3) to the bathing solution reversibly
blocked the spike induction in ND4 cells (Figure S3B), suggest-
ing that the APs were generated by the activation of voltage-
dependent Na+ channels. Moreover, all cells received strong
spontaneous synaptic input (Figure S3C, left graphs), either
GABAergic, as hyperpolarizing potentials or outward currents
recorded under voltage-clamp conditions at 60mV could be
as reversibly inhibited by the GABAa receptor antagonist bicu-
culline (10 mM) (Figure S3C, middle trace), or glutamatergic, as
revealed by reversible blockage by the AMPA-receptor antago-
nist NBQX (10 mM) (Figure S3C, right trace).
As the above data demonstrate that reprogrammed neurons
receive functional synapses, we next examined whether they
were also competent to form synapses by recording ND4 or
ND4+I reprogrammed neurons in the absence of (E)14.5 pri-
mary neuronal co-cultures. Already at 8 DPT both ND4 and
ND4+I neurons were able to form functional synapses as indi-
cated by the existence of autaptic responses. In ND4-induced
neurons, step-depolarizations during voltage-clamp recordings
to membrane potentials of 10mV to 0mV elicited autaptic cur-
rents (2/11 neurons recorded), which were blocked by NBQX
(5–10 mM), thus indicating that these autaptic responses were
mediated by synaptically released glutamate via the AMPA-
receptor (Figure 4F). Of 12 ND4+I-induced neurons tested, 8
showed autaptic responses that were in all tested cases (5/5)
glutamatergic, as they were suppressed by NBQX (5–10 mM;
reversible after a prolonged washout period, n = 1, Figure 4G)
but not by the GABAA receptor antagonist bicuculline (n = 4).
In agreement with electrophysiological data, ND4+I neurons
were immunopositive for the synaptic vesicular glutamate
transporter vGluT1 (Figure 4H). Thus, the common factors
ND4+I induce a glutamatergic neuronal phenotype from cere-
bral cortex astrocytes.
NeuroD4 and Insm1 Reprogram Murine Fibroblasts and
Human Astrocytes
Todeterminewhether the identifiedcombinationsof downstream
proneural targets also have a reprogramming activity in other cell
types, we expressed them in mouse embryonic fibroblasts
(MEFs) (Vierbuchen et al., 2010) and human astrocyte cultures
(same cells as inGuo et al., 2014). InMEFs, onlyND4+I generated
bIII-tubulin+ cells at 14 DPT (Figures S4A–S4D, quantification in
Figure S4E), while ND4 alone (Figure S4C) or in combination
withother targets failed todoso (datanot shown). In humanastro-
cyte cultures (Figures S4F and S4G0), bIII-tubulin+ cells appeared
in samples transducedwith ND4 alone or in combination with the
selected genes already at 8 DPT (Figures S4I–S4L, quantification
in M), but not in control cells (Figure S4H). Thus, these down-
stream transcription factors are also sufficient to reprogram cells
from other species or germ layers.
Astroglia Reprogramming Is Impaired when
Neurog2ERT2 Activation Is Delayed
As astrocytes at postnatal stages are still plastic and proliferate
(Ge et al., 2012; Laywell et al., 2000), we tested how reprogram-
ming would be affected if astrocytes were cultured for a longer
time. To this end, we maintained Neurog2ERT2-transduced
murine astroglial cells in culture for 6 or 8 extra days (data not
shown) before starting OHT treatment for 6 days (Figure 5A; con-
dition is referred to as ‘‘delayed induction’’ or prolonged culture
[6 days after passaging], while the condition described in Fig-
ure 1A is referred to as ‘‘early induction’’ [1–2 days after
passaging]). Similar to the untreated controls (Figures 5B and
5D), very few neurons appeared in OHT-treated Neurog2ERT2-
transduced prolonged cultures (Figures 5C and 5D) with the ma-
jority of them still expressing GFAP and maintaining astroglial
morphology. Likewise, delayed induction of Ascl1ERT2 also
impaired reprogramming significantly, albeit less dramatically
than for Neurog2ERT2 (data not shown). Therefore, prolonged
culture of astrocytes renders them more resistant to proneural
factor-induced reprogramming, which is similar to previous re-
sults obtained by multiple passages of astrocyte cultures (Price
et al., 2014).
The expression of the selected downstream targets was
examined after delayed induction, and NeuroD4 was the
only target still upregulated by Neurog2ERT2, albeit 5-fold
less than it was after early activation of Neurog2ERT2 (Fig-
ure 5E). ChIP-qPCR on early OHT-treated Neurog2ERT2-
transduced cells revealed that Neurog2ERT2 was significantly
enriched at several of its downstream targets (Atoh8, Insm1,
NeuroD1, NeuroD4, Prox1, Sox11, and Trnp1; Figure 5F,
ChIP early), indicating that Neurog2ERT2 directly activates
these targets in astroglia by binding to their regulatory
elements. However, with the delayed induction protocol,
Neurog2ERT2 was bound less to NeuroD1, NeuroD4, and
Trnp1 promoters (Figure 5F), which is statistically not different
from the negative control region (Dll1 ORF). Thus, astroglial
cells in culture are not in a stable permissive state for reprog-
ramming but they become increasingly refractory to conver-
sion into neurons, a process that might involve a reduced
accessibility of Neurog2 to target genes important for the re-
programming process.
Selected Target Genes Downstream of Neurog2 and
Ascl1 Induce Reprogramming of Prolonged Astroglia
Cultures
If the failure of target gene activation is responsible for the low
reprogramming efficiency in the prolonged cultures, this should
be overcome by expression of these targets (Figure 5G). Indeed,
in cultures maintained for a longer time, combinations of ND4
with Insm1, Prox1, or Sox11 elicited the generation of neuronal
cells (Figures 5I and 5J) more efficiently than ND4 alone (Figures
5H and 5K). Likewise, combining Neurog2ERT2 with Insm1,
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NeuroD4, Prox1, or Sox11 led to neuronal reprogramming also in
prolonged cultures, while cells co-transduced with
Neurog2ERT2 and a control virus largely remained astroglia (Fig-
ures S5A–S5E, quantification in Figure S5F).
Thus, impairment in neuronal reprogramming in prolonged
astroglial cultures is due to a failure in the activation of these
common neurogenic fate determinants while the underlying
downstream neurogenic program is still amenable for activation.
REST Represses NeuroD4 Transcription in Competition
with Neurog2
The reduced Neurog2ERT2 binding to target loci upon delayed
activation suggested that changes in the chromatin state might
take place at these target loci (see Hirabayashi and Gotoh,
2010 for review). We focused on NeuroD4 as one of the main
target genes mediating the reprogramming activity of Neurog2
and Ascl1 in astroglial cells. Between the cultures collected at
different time points, we did not observe any significant change
in the repressive marks H3K27me3 and 5mC or the active mark
H3K4me3 analyzed by ChIP-qPCR at several locations in this
gene, including the Neurog2ERT2-bound enhancer, intron, and
promoters (Figures S6A–S6E), while H4K20me3 was enriched
in prolonged cultured astrocytes compared to short-term cul-
tures (Figures 6A and 6A0). These data suggest that remodeling
of the chromatin at NeuroD4 locus occurred over time such
that it became more heterochromatin-like (Wongtawan et al.,
2011).
As a repressor complex might be involved in such a change,
we focused on REST, known to repress neuronal gene expres-
sion in non-neural cells (Jørgensen et al., 2009). By ChIP-
qPCR, REST was confirmed to be present at the NeuroD1/4
loci in astroglial cells soon after plating (Figures 6B and 6B0)
(Gao et al., 2011; Johnson et al., 2008). REST ChIP following
early activation of Neurog2ERT2 showed significantly reduced
binding onto the NeuroD4 promoter and less so on the Neu-
roD1 or Sox11 promoters (Figures 6C and 6C0). In contrast,
Neurog2ERT2 delayed activation had no effect on REST bind-
ing (Figures 6C and 6C0), suggesting that the proneural factor
Neurog2 and REST can compete for binding at this site in early
cultures, but no longer at later stages. Importantly, western blot
analysis revealed that REST protein level was unchanged over
time (Figures S6F–S6F0 0), thus excluding the possibility that
Neurog2 could compete with REST early on but not late
because of a higher abundance of REST protein in prolonged
cultures.
To directly investigate the role of REST in preventing astroglia
reprogramming in prolonged cultures, we generated astroglia
cultures from P6 cerebral cortex of mice homozygotes for a
new conditional allele of REST (hereafter referred to as RESTflox,
see Experimental Procedures and Figure S6G) and transduced
them with a Cre-recombinase-encoding adenovirus either
immediately after passaging the astrocytes or with a 5 day delay.
In both conditions, REST protein disappeared within 48 hr (Fig-
ures S6H–S6H0, black arrow). As Cre-mediated recombination
removes exon 2 (Figure S6G) and a truncated form appeared
in the western blot (Figure S6H0, empty arrow), we verified that
this truncated form has no binding capability (i.e., no significant
difference in enrichment between REST-ChIP and mock-ChIP
samples, and 5- to 10-fold reduced binding capability compared
to REST-expressing astrocytes; Figure S6I, and for comparison,
Figure 6B). Thus, Cre-mediated deletion of exon 2 generates a
truncated form of REST unable to bind to DNA. Upon REST dele-
tion in short-term cultures, both NeuroD1 (Gao et al., 2011) and
NeuroD4 were upregulated, while REST ablation in prolonged
cultures had no significant effect on NeuroD1 or NeuroD4
expression (Figures S6J–S6J0).
To test whether REST could prevent Neurog2ERT2 from bind-
ing to theNeuroD4promoter in astrocytescultured for 6days (Fig-
ure 6D), we co-infected the cultures with Cre and Neurog2ERT2,
thus deletingREST from thebeginning of the culture, and initiated
OHT treatment 6 days later. ChIP-qPCR revealed a significant in-
crease of Neurog2ERT2 onto NeuroD4 promoter compared to
REST-expressingcells,with a small effect onNeurog2ERT2bind-
ing to Atoh8 and NeuroD1 loci (Figure 6D0). In these conditions
(early REST deletion and delayed Neurog2ERT2 activation, Fig-
ure 6E), NeuroD4 and Trnp1 were upregulated (Figure 6E0,
gray bars). However, when REST was removed 5 days after
Neurog2ERT2 transduction (Figures 6E and 6E0), NeuroD4 was
not upregulated after Neurog2ERT2 delayed activation (Fig-
ure 6E0, black bars).
Together, these data suggest that NeuroD4 becomes less
prone to activation over time, likely through the initial transient
Figure 4. Generation of Synaptically Mature Neurons upon Combined Expression of Downstream Targets
(A) Schematic representation of the experimental procedure.
(B–D) Electrophysiological characterization of induced neurons upon overexpression of the constructs indicated by live fluorescence during recordings.
Examples of sustained trains of APs generatedwhen recording in current-clampmode are shown (in B0, C0, and D0 top panel: stimulation protocol). 50% repetitive
firing NeuroD4/GFP cells present first spike latency lower than 70ms, with 50% higher than 150ms; an example of frequency adaptation is shown (B0 0 and B0 0 0 ). In
(C0), an example of a repetitive AP generated in NeuroD4/Insm1 transduced cells is shown (four generated the first spike with a latency lower than 70 ms and the
remaining two did so with a latency higher than 150ms) and characterized by spike accommodation (C0 0) and spike adaptation (C0 0 0). (D0 0 and D0 0 0 ) show examples
of repetitive spike discharge in NeuroD4+Prox1-expressing neurons. (B0 0 0 0–D0 0 0 0) A pie chart shows the fraction of cells firing bursting (gray), transient (blue), or
sustained (yellow) APs.
(E) Table summarizing the electrophysiological parameters measured (brackets indicate the number of cells analyzed).
(F) Example of NeuroD4-induced neurons at 14 DPT (F0). A depolarizing current pulse (1 s, 85 pA) induced a train of APs (F0 0). In (F0 0 0) the autaptic response (black
trace, average of 10) could be blocked by NBQX (5 mM, red trace, average of 10).
(G and G0) Example of NeuroD4-Insm1-induced neurons at 14 DPI. A depolarizing current pulse (1 s, 230 pA) induced a train of APs (G0 0). In (G0 0 0) the autaptic
responses (black trace, average of 10) could be blocked by NBQX (10 mM, 10 min red trace, average of 10) and partially reversed following washout for 45 min
(blue trace).
(H) Micrograph depicting a neuron induced by co-expression of NeuroD4-containing viral vector (red) and Insm-containing viral vector (green) immunostained at
30 DPI for MAP2 (H0, blue) and vGlut1 (H0 0, white). Scale bar, 50 mm.
See also Figure S3.
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repressor activity of REST followed by a histone modification
that makes the locus more compact.
REST Deletion Alleviates the Reprogramming Blockage
in Prolonged Astrocytic Cultures
To examine the effect of REST deletion onNeurog2ERT2-depen-
dent neuronal conversion, RESTflox astrocytes were co-infected
with Neurog2ERT2- and Cre-encoding viruses soon after being
plated, or with a 5 day delay (Figure 7A). Cultures were then
treated for 3 consecutive dayswith OHT and analyzed 8 DPI (Fig-
ures 7B–7E, Figures S7A–S7D). As previously reported (Xue
et al., 2013), REST deletion generated a fraction of bIII-tubulin+
cells on its own without Neurog2ERT2 activation (around 20%,
Figure 7F); strikingly, however, 90% of Cre/Neurog2ERT2 trans-
duced cells were bIII-tubulin+ after early REST deletion and
delayed Neurog2ERT2 activation (Figure 7D). Delayed Cre-
mediated REST deletion still allowed 50% of Cre/Neurog2ERT2
double positive cells to convert into bIII-tubulin+ neurons after
induction (Figure 7D), suggesting that other mechanisms are
gradually taking over to block reprogramming.
Thus, REST is a key factor in silencingmain neurogenic targets
of proneural factors such that they are no longer accessible for
reprogramming in astrocytes in prolonged cultures.
DISCUSSION
The present study unraveled the transcriptional events taking
place in the initial phases of astrocytes converting into neurons.
This conversion occurred swiftly, in a dynamic manner, and with
very distinct transcriptional programs between the proneural
factors Ascl1 and Neurog2. Thus, even within the same cell
type from the same brain region maintained in the same environ-
ment, forced induction of glutamatergic and GABAergic
neuronal fate follows essentially distinct paths, with relatively
few genes common to both neurogenic cascades. The analysis
of the identified shared target genes led us to identify a particu-
larly important subset of downstream targets capable, when
combined, of directly reprograming astrocytes into functional
neurons. Among these, NeuroD4 seems instrumental to force
direct reprogramming, and investigating the failure of NeuroD4
induction in reprogramming-resistant astrocytes led us to un-
cover an important mechanism of chromatin accessibility control
at the NeuroD4 locus. Indeed, the binding of REST close to the
NeuroD4 promoter prevents the recruitment of Neurog2, while
accumulation of H4K20me3 occurred over time. Therefore, this
work sheds light on some of the earliest mechanisms decreasing
astrocyte reprogramming into neurons.
Similarities and Differences between Gene Regulation
in Development and Direct Reprogramming
Activation of Neurog2ERT2 or Ascl1ERT2 in astroglia cells re-
vealed a highly dynamic regulation of gene expression within
the first 48 hr of direct reprogramming: only a small subset of
genes (7% and 13.5% for Neurog2 and Ascl1, respectively)
was regulated at least at two time points (Figures S1P and
S1P0), suggesting a fast and hierarchical sequence of gene regu-
lation. About one-third (188 out of 626) of the genes regulated by
Neurog2ERT2 at any time in our analysis are common to the
genes regulated by Neurog2 in the developing cerebral cortex
in vivo (Gohlke et al., 2008), and similar results were obtained
by comparing Ascl1ERT2-regulated genes with Ascl1-electro-
porated cells in vivo (527 out of 1,669; Gohlke et al., 2008). The
proportion of commonly regulated genes is rather low (18% at
48 hr, Figures S7E and S7F) when compared to Ascl1-regulated
genes in neuronal reprogramming of MEFs (Wapinski et al.,
2013). However, this expression analysis was performed at
48 hr with tetracycline-inducible cells, and, given the fast dy-
namic regulation of targets observed here, we can only conclude
that at least some common target genes are activated during re-
programming of cultured MEFs or astrocytes (Table S7). These
are enriched for neuronal differentiation and axon-related genes
(Figure S7G, Table S7), such as Dll3, Dcx, neurofilaments, and
the known targets Dlx2/3. Hes6 was the only gene present in
all the transcriptome data examined (Neurog2ERT2, Ascl1ERT2,
in vivo Neurog2, Ascl1 gain-of-function, Neurog2 loss-of-func-
tion (Gohlke et al., 2008), and Ascl1 in MEFs (Wapinski et al.,
2013)) with 14 genes present in at least five different analyses
(Arl4A, Coro2B, Cxadr, Dll3, Efhd2, Gpm6B, Hes5, Homer2,
Isl1, Lrrc17, Plk3, Rgs16, and Shf). Thus, even in very different
cell types at different developmental stages, some common
target genes regulated by these proneural factors emerge.
Identification of Common Neurogenic Factors
Among the genes regulated by Neurog2 and Ascl1 in astrocyte
reprograming, many are pan-neuronal, such as Elavl2, synuclein
a (Snca), neuronal pentraxin (Nptx1), D11Bwg0517e (Rfox3, also
known as NeuN), and bIII-tubulin (tubb3), as well as several
key neurogenic transcription factors widely expressed in
Figure 5. Delayed Induction of Neurog2ERT2 Reveals a Block in Astrocyte Reprogramming
(A) Scheme of the experimental procedure.
(B and C) Micrographs of Neurog2ERT2-infected astrocytes (red) immunostained for GFAP (green) and bIII-tubulin (white), without (B) or with (C) OHT treatment
starting at 6 days after being plated. Scale bars, 100 mm.
(D) Histogram depicting the proportion of GFAP+ or bIII-tubulin+ cells among infected cells upon delayed Neurog2ERT2 activation at 13 DPI. n = 4 independent
experiments.
(E and F) Histograms of real-time qPCR (E) and HA-Neurog2ERT2 mChIP-PCR (F) of astrocyte cultures treated as indicated in the legend (early, early OHT
treatment, gray bars in E from Figure 1A; and delayed, OHT treatment 6 days later). For (F) cells were exposed to OHT treatment for 24 hr. Percentages of input
chromatin were quantified in duplicate from three independent biological samples (mean ± SEM). Significance was tested between samples and respective Dll1
ORF negative region by two-tailed unpaired t test (*p < 0.05, **p < 0.01, ***p < 0.0001).
(G) Scheme of the experiment.
(H–J) Micrographs of astrocytes transfected with the constructs indicated on top of the panels with a 5 day delay immune-stained for bIII-tubulin 8 days post
transfection (DPT). Scale bars, 50 mm.
(K) Histogram depicting the proportion of bIII-tubulin+ cells at 8 DPT. Mean ± SEM; n = 4 independent experiments (*p < 0.05).
See also Figure S5.
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neurogenesis, reflecting their implication in many different
neuronal lineages (Figure 1H, Table S6).
Loss-of-function studies on the common downstream targets
revealed their crucial role in mediating Neurog2- and Ascl1-
induced reprogramming (Figure 2). Interestingly, most of the
cells transduced with Neurog2 and specific miRNAs for these
targets (Hes6, Insm1, NeuroD4, and Sox11) were negative for
both the neuronal marker bIII-tubulin and the astroglial marker
GFAP (Figure 2D), suggesting that activation of these targets is
not required to block the astroglial fate but rather to induce the
neuronal fate. Conversely, the combination of just two of these
common neurogenic transcription factors is sufficient to trigger
reprogramming of cells into functional neurons from both mouse
astroglia (Figures 3, 4, and S3) and human astrocytes and MEFs
(Figure S4), suggesting that the identified targets mediate critical
biological processes required to induce the neuronal fate, such
as transcriptional regulation and cytoskeleton reorganization.
Among the factors tested, NeuroD4was the only gene capable
of reprograming astrocytes into functional neurons on its own.
However, only a minority of NeuroD4-induced neurons seem
to complete synaptic maturation, while the co-expression of
Insm1 seems sufficient to allow them to reach a fully mature
Figure 6. Chromatin Marks and REST Binding at Regulatory Regions of the Downstream Targets NeuroD4, NeuroD1, and Sox11
(A and A0) H4K20me3 mChIP-PCR on immunoprecipitated material from astroglia cultures collected 1 day or 6 days after being plated as indicated in the scheme
at top of (A).
(B and B0) Analysis of REST binding to NeuroD4 by mChIP-PCR on immunoprecipitated samples from short-term astroglia cultures as indicated in the scheme in
(B). Amplification of the REST binding element within theNeuroD1 intron was used as a positive control while a region within the promoter of Sox11 was used as a
negative control. Percentages of input chromatin were quantified in duplicate from three independent biological samples (mean ± SEM).
(C and C0) REST mChIP-PCR on immunoprecipitated samples from Neurog2ERT2-transduced astrocytes cultured for shorter or longer periods and treated with
OHT for 24 hr as indicated at the top of (C). REST ChIP values were normalized to their respective mock ChIP values (mean ± SEM in duplicate from three
independent biological samples; two-tailed unpaired t test, *p < 0.05).
(D and D0) HA-Neurog2ERT2 mChIP-PCR on immunoprecipitated genomic DNA from delayed astroglia cultures. RESTflox cKO were transduced with
Neurog2ERT2 and adeno-Cre virus with a late OHT induction as indicated (D). The Atoh8 promoter and NeuroD1 promoter regions were used as controls for the
effect of REST deletion on Neurog2 binding. Percentages of input chromatin were quantified in duplicate from three independent biological samples (mean ±
SEM; two-tailed unpaired t test, *p < 0.05).
(E and E0 ) Real-time qPCR analysis on Neurog2ERT2-astrocytes treated with OHT for 48 hr after early or late REST Cre-mediated deletion as indicated at the top
of the histogram (E). Control samples (Cre- OHT+) were transduced with adeno null virus 1 day after being seeded at the same time as the delayed Cre sample
(adeno-Cre virus, Early Cre+OHT+). In parallel, another set of cells was transduced with adeno-Cre virus 5 days later (Delayed Cre+OHT+). Mean ± SEM in
duplicate from three independent culture batches.
See also Figure S6.
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synaptic glutamatergic phenotype. Thus, the NeuroD family of
bHLH transcription factors (including also NeuroD1 and 2; Guo
et al., 2014; Yoo et al., 2011) appears to be particularly important
in neuronal reprogramming.
REST Is a Critical Repressor of NeuroD4
When Neurog2ERT2-transduced astrocytes were maintained in
culture for 6 days before OHT treatment, only a small fraction
of them converted into neurons, most likely as a consequence
of the reduced induction of some targets, such as NeuroD4 (Fig-
ure 4E), suggesting that within this short period of time reprog-
ramming blocks were already established.
Examining the chromatin landscape changes at the NeuroD4
locus, we detected an enrichment of the heterochromatin-asso-
ciated histone mark H4K20me3 (Wongtawan et al., 2011) at the
NeuroD4 promoter in prolonged cultured cells, suggesting a
Figure 7. Deletion of REST Removes Reprogramming Block in Astrocytes
(A) Schematic representation of the experimental procedure.
(B–E) Micrographs of Neurog2ERT2-infected astrocytes (red) with early (B and C) or late (D and E) deletion of REST by infection with a Cre containing viral vector
(green) immunostained for the neuronal marker bIII-tubulin (white) at 8 DPI. Yellow arrowheads indicate triple positive cells (DsRed, YFP, bIII-tubulin) while white
arrowheads indicate double positive cells (DsRed, GFP). Scale bars, 150 mm.
(F) Histogram depicting the proportion of co-transduced double positive cells (red and green) for the astrocytic marker (GFAP, white bars) or the neuronal marker
(bIII-tubulin, black bars). Mean ± SEM, three independent biological samples; two-tailed unpaired t test, *p < 0.05; ***p < 0.001.
(G) Postnatal (day 6–7) mouse cortical astrocytes transduced with Ascl1 or Neurog2 are reprogrammed into neurons. However, when cells are maintained longer
in culture, increasing levels of H4K20me3 modify the local chromatin environment that becomes favorable to the repressive complex REST. Consequently,
Neurog2 fails to access the NeuroD4 promoter. This is bypassed by common downstream transcription factors to both Ascl1 and Neurog2 that are able to
generate neurons also in prolonged astrocytic cultures. Unidentified REST co-factors might be recruited to the locus to further remodel the chromatin over time.
See also Figure S7.
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progressive reduction of chromatin accessibility at this locus.
Interestingly, REST is highly enriched at both NeuroD1 and Neu-
roD4 loci initially but less at the NeuroD4 promoter in astrocytes
cultured for 6 more days (Figure 6C0), suggesting that REST is
important in initiating the silencing of NeuroD4, but additional
repressive mechanisms may be involved at later stages. Consis-
tent with this hypothesis, the binding competition between
Neurog2 and REST only occurred in cultures soon after they
were plated (Figure 6C0), and a strong activation of NeuroD4 in
prolonged cultures occurred only upon early deletion of REST
(Figure 6E). These observations thus revealed a temporal win-
dow during which REST binding/activity can be modulated.
REST ablation resulted in a striking improvement of reprog-
ramming efficiency upon delayed Neurog2ERT2 activation
when REST was deleted early but also when it was deleted
late, thus suggesting important functions of REST-regulated
genes other than NeuroD4 in astrocyte reprogramming. Further
studies will be required to examine the mechanism underlying
the essential role of REST in orchestrating gene silencing in as-
trocytes (Figure 7G). In different cell types, recruitment of other
factors, such as HP-1 or HDAC1, is important to further silence
gene transcription. However, we did not observe a significant
difference in HP-1 or HDAC1 binding to NeuroD4 between
short- and prolonged astroglia cultures (data not shown).
REST has recently been implicated in PTB-regulated miRNA-
based MEF reprogramming (Xue et al., 2013) and identification
of specific co-factors/regulators needs to be explored in
astrocytes.
Importantly, our results revealed a hierarchical mode of target
gene blockage mediating alternative fates. While Neurog2 could
no longer regulate some of its targets, such as NeuroD4, in pro-
longed cultures, the targets of NeuroD4 are still accessible, since
NeuroD4 with or without an additional common factor could still
mediate reprogramming as efficiently as in short-term cultured
astrocytes. Thus, our data suggest a developmental hierarchy
in shutting off genes of alternative fates, a novel concept in eluci-
dating the hurdles for direct reprogramming.
EXPERIMENTAL PROCEDURES
Cell Cultures of Astroglia from the Postnatal Mouse Cerebral Cortex
Astrocytes were cultured as previously described (Heinrich et al., 2010; Heins
et al., 2002). MEFs were isolated as described (Vierbuchen et al., 2010).
Human astrocytes were purchased from ScienCell (cat. #1800) and expanded
as described in the protocol. For details on cell culture see the Supplemental
Experimental Procedures.
Immunocytochemistry
Cells were fixed and stained as previously described (Heinrich et al., 2011). For
details and antibodies used see the Supplemental Experimental Procedures.
RNA Extraction and Real-Time qPCR
6 to 12 wells from 24-well plates were collected for each time point. Subse-
quently, RNA was extracted with the RNeasy Plus Micro Kit (QIAGEN) accord-
ing to the manufacturer’s instructions, and genomic DNA was removed. RNA
was retro-transcribed with SuperScriptIII Reverse Transcriptase and Random
Primers (Roche). Each cDNA sample was diluted 1:5 and 1 ml was used for
each quantitative real-time reaction. Real-time qPCR was performed on a
LightCycler480 instrument (Roche) with the LightCycler Probe Master kit
(Roche) and Monocolor Hydrolysis Probe (UPL) Probe (Roche) according to
the manufacturer’s instructions (20 ml final volume). The expression of each
gene was analyzed in triplicate. Data were processed with the DDCt method
(Livak and Schmittgen, 2001). Quantification was performed on three indepen-
dent samples. Primers and probes are listed in the Supplemental Experimental
Procedures.
Microarray Analysis
10 mg of amplified antisense RNA (aRNA) was hybridized on Affymetrix Mouse
Genome 430 2.0 arrays containing about 45,000 probesets. Staining and
scanning was done according to the Affymetrix expression protocol. GO
term analysis was performed using DAVID (http://david.abcc.ncifcrf.gov).
For details see Supplemental Experimental Procedures.
Plasmids and DNA constructs
cDNA of selected genes was subcloned into self-inactivating retroviral vectors
containing the actin promoter with cytomegalovirus enhancer (pCAG) driving
the expression of the genes of interest linked to a fluorescent reporter through
internal ribosomal entry site (IRES) as previously described (Heinrich et al.,
2011). Flag-HA-Ascl1ERT2 and Flag-HA-Neurog2ERT2 were obtained by
a fusion of the transcription factor cDNA together with the ERT2 domain of the
estrogen receptor. For ChIP experiments, DsRed cDNA present in pCAG-
Neurog2ERT2-IRES-DsRed was replaced with Puromycin cDNA to allow cell
selection in the culture. For details see the Supplemental Experimental
Procedures.
Micro-ChIP and qPCR
Around 100,000 cells per sample were used for micro-ChIP (mChIP). For details
see the Supplemental Experimental Procedures.
Western Blot
Cells were washed three times with 1X cold PBS, lysed with urea buffer (8M
urea, 1M thiourea, 0.5% [w/v] CHAPS, 50mM DTT, and 24mM spermine),
scraped with a sterile disposable cell scraper (Costar), transferred to an
Eppendorf tube, and centrifuged at 14,000 rpm at room temperature for
30 min. Equal amounts of protein were loaded onto polyacrilamide gels (No-
vex, Life Technologies) and blotted with anti-REST (1/200; Millipore, 07-579)
or anti-LaminB (1/1000; Santa Cruz, sc-6216 and sc-6217).
Patch-Clamp Recording
Whole-cell current-clamp recordings were made using an npi ELC-03XS
amplifier (npi, Tamm, Germany), which allowed current-clamp recordings in
bridge mode and voltage-clamp measurements. For further information, see
the Supplemental Experimental Procedures.
Conditional REST Mouse Line
Mouse ESCs targeted with the L1L2_Bact_P cassette were obtained from the
Sanger EUCOMM project (clone EPD0105_1_E05, http://www.informatics.jax.
org/allele/key/609045) and injected into blastocysts to generate heterozygous
animalswith loxPsites flanking the secondexonofREST.Subsequent crossings
with Rosa26-floxed stop-YFP reporter mice (Srinivas et al., 2001) were per-
formed to generate a homozygous RESTflox/R26YFP line. In order to remove
the neo selection cassette from theREST locus, we crossedRESTneoflox animals
with the Flip recombinase mouse line. Experiments conducted with RESTflox
mice were performed in accordance with a UK Home Office Project License
and approved by the local ethics committee. All animal procedures were carried
out in accordance with the policies of the use of animals and humanmaterial of
the EU and the institutional animal committees implementing them.
ACCESSION NUMBERS
Array data have been submitted to GEO under the accession number GEO:
GSE60389.
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Supplementary Figure legends 
 
Figure S1. Related to Figure 1 
Inducible reprogramming and genome-wide expression analysis 
(A) Schematic drawing of the experimental design for Figure S1B-C. 
(B,C) Micrographs of astrocytes 1 day (B) and 7 days (C) after plating 
immune-positive for LeX (red) and GFAP (green). Scale bar: 100µm. 
(D) Histogram showing the proportion of LeX+ cells/GFAP+ in astrocytic 
cultures at day 1 and day 7. (n=3 independent experiment).  
(E) Schematic drawing of the experimental design for Fig. S1F-J. 
(F-J) Micrograph of GFP-transduced astrocytes at day 2 (F, I, J) and day 7 
(G) immunoreactive for LeX (F, G, red), GFAP (F-J, white), Aldh1l1 (I, red) or 
Glast (J, red). 
(H) Histogram showing the proportion of LeX+/GFP+ cells in astrocytic 
cultures at day 1 and day 7. (n=4 independent experiment). 
(K) Schematic drawing of the experimental design. 
(L, M) Histograms depicting the proportion of GFAP+ astrocytes and βIII-
tubulin+ neurons after transduction with the constructs indicated and OHT 
treatment as indicated by the black bar below the histograms. Mean ± SEM; 
n=4 independent experiments; Statistical test ANOVA and Bonferroni’s 
multiple Comparison Test (*=p<0.05; ***=p<0.001). 
(N) Micrographs depicting astrocytes infected with the constructs indicated on 
the right side of the panels and immunostained for Neurog2 (green in middle 
panel of the upper row) or the flag-tag of Ascl1ERT2 (green in middle panel of 
the lower row) in DsRed-expressing cells at 24 hours after OHT treatment at 2 
days post infection. Scale bar: 100µm. 
(O-O’) Quantification of transduction efficiency in Neurog2ERT2-expressing 
cells (F), or Ascl1ERT2-transduced cells (F’) in absence or presence of OHT 
for 24 hours. 
(P-P’) Venn diagrams showing the number of genes significantly regulated in 
Neurog2ERT2 (P) or Ascl1ERT2 (P’) at the time points indicated in the 
diagrams. 
	  	  
(Q,R) Venn diagram showing the number of genes significantly regulated by 
Neurog2ERT2 and Ascl1ERT2 at 4 hours (Q) and 48 hours (R) following OHT 
treatment. 
(S) Gene Ontology (GO) terms enriched in the genes regulated by both 
Neurog2ERT2 and Ascl1ERT2 at 24 hours following OHT treatment. 
 
Figure S2. Related to Figure 2 
Validation of microRNA (miRNA) 
 Histograms depicting the fold change in expression determined by Real Time 
qPCR with RNA extracted from cells transfected with the indicated constructs. 
In red the results obtained with the microRNA selected for further experiments 
(Figure 2). 
 
Figure S3. Related to Figure 3 and 4 
Combinations of downstream targets and characterization of ND4-
reprogrammed neurons co-cultured with E14.5 neurons. 
 (A) Histogram depicting the proportion of βIII-tubulin+ neurons amongst the 
astrocytes co-transduced with the plasmids indicated on the x-axis in 2-6 
independent culture batches depending on the combinations. 
(B) Electrophysiological recordings of ND4-reprogrammed neurons at 28-25 
DPI. Lack of effects of NBQX and D-AP5 on action potentials (second trace), 
while addition of TTX blocked the spike induction (third trace) in a reversible 
manner (fourth trace) (n=3 cells recorded). 
(C) Effect of bicuculline addition (middle traces) and NBQX and D-AP5 (right 
traces) on the reprogrammed neurons. Note that hyperpolarizing events or 
outward currents recorded under voltage-clamp conditions at -60mV could be 
inhibited by the GABAA receptor antagonist bicuculline. Moreover, the AMPA-
receptor antagonist NBQX and the NMDA-receptor antagonist D-AP5 could 
block the synaptic potentials or currents. 
 
 
 
	  	  
Figure S4. Related to Figure 4 
Combinations of downstream targets reprogram murine embryo fibroblasts 
and human astrocytes 
(A) Schematic drawings of the experiment design for Fig. S4B-E. 
(B-D) Example of MEFs transduced with Control (B) NeuroD4 (C) and 
NeuroD4 and Insm1 (D). Note that only NeuroD4+Insm1 gave rise to βIII-
tubulin+ (D, D’’’) cells at 14DPI. 
(E) Histogram depicting the proportion of βIII-tubulin+ cells among reporter 
positive cells, (n=3 independent experiment). 
(F,G) Human astrocytes are positive for GFAP (G) and the human nuclei 
marker (F’) while mouse astrocytes only for GFAP (G, G’). Scale bar: 100µm. 
(H-L) Examples of human astrocytes transduced with retrovirus encoding the 
indicated genes. Scale bar: 100µm.
(M) Histrogram depicting the proportion of βIII-tubulin+ cells over the 
transduced ones. (n=2 independent cultures).  
 
Figure S5. Related to Figure 5.  
Expression of downstream targets together with Neurog2ERT2 rescues 
reprogramming upon Neurog2ERT2 delayed induction. 
(A) Schematic drawing of the co-transduction of Neurog2ERT2 (red) and a 
second gene (green) followed by delayed activation of Neurog2ERT2. 
(B-E) Examples of astrocytes transduced with the Neurog2ERT2 and the 
indicated factors and analysed 7 days after the first induction. Inserts show 
that the cells are DsRed+ (B’, C’, D’, E’), GFP+ (B’’, C’’, D’’, E’’) and βIII-
tubulin+  (B’’’, C’’’, (D’’’, E’’’). Scale bars= 100µm. 
(F) Histogram depicting the proportion of βIII-tubulin+ neurons among 
DsRed/GFP double+ co-transduced cells at 7 days post differentiation. Mean 
± SEM; n=3 independent experiments; (*=p<0.05). 
 
 
 
 
	  	  
Figure S6. Related to Figure 6.  
Epigenetic marks at NeuroD4 regulatory regions and analysis of REST 
expression and function. 
(A) Schematic representation of the mouse Neurod4 locus. Red and blue 
triangles represent Neurog2 and REST binding sites respectively and black 
squares represent exons. Green lines indicate positions of primers used in 
real time qPCR. 
(B) Timeline of sample collection for µChIP analysis. 
(C) H3K27me3 µChIP-PCR on immunoprecipitated material from astroglia 
collected 1 day or 6 days after plating. 
(D) H3K4me3 µChIP-PCR on immunoprecipitated material from astroglia 
collected 1 day or 6 days after plating. 
(E) 5’mC and 5’hmC µChIP-PCR on immunoprecipitated genomic DNA from 
astroglia collected 1 day or 6 days after plating. 
(F) Timeline of sample collection for Western Blot analysis. 
(F’-F’’) Western blot analysis of total cell lysate from early and prolonged 
cultured astroglia. Equal amounts of protein were loaded onto gels and blotted 
for REST and LaminB (loading control). Note that REST protein levels do not 
increase during astrocyte maturation in these culture conditions. (F’’) 
Histogram depicting the quantification of the Western blot results as shown in 
(F') from three independent biological samples with ImageJ, two-tailed 
unpaired t-test n.s= p>0.05. 
(G) Schematic representation of the conditional REST mutant allele. The 
second exon (black square) is flanked by loxP sites (red triangles). The green 
triangle is the remaining FRT site after neo cassette removal. 
(H) Experimental design for early or late REST deletion by Cre in an 
adenoviral vector added to the cultured astrocytes as indicated. 
(H’) Western blot of total cell lysate from early and delayed cultures. Cells 
were transduced with an adenoviral vector serving as a control and lacking 
Cre (lane 1and 3) or Cre-encoding adenovirus (lane 2 and 4) for 48 hours. 
Equal amounts of protein were loaded onto gels and blotted for REST and 
LaminB (loading control for nuclear proteins). Lower band (empty arrowhead) 
	  	  
is a truncated form of REST lacking exon2, unable to bind DNA (see Figure 
S6I).   
(I) Histogram depicting REST µChIP-PCR on immunoprecipitated genomic 
DNA from REST-cKO astrocytes collected 48 hours after infection with Cre-
expressing adenovirus. No significant difference was observed between mock 
ChIP and REST-ChIP. The experiments were performed in parallel to those in 
Fig. 6B: note that in Fig. 6B the enrichment is 4-5 time higher, indicating an 
almost complete loss of REST expression. 
(J) Timeline of mRNA analysis following Cre-mediated REST deletion. 
(J’) Histogram depicting the expression of selected genes determined by real-
time qPCR upon early or delayed REST deletion. Note that NeuroD1 and 
NeuroD4 are expressed at higher levels upon early REST deletion but not 
following late REST ablation. 
 
Figure S7. Related to Figure 7.  
GFAP expression upon REST deletion. 
(A-D) Examples of GFAP (white) expression in RESTflox astrocytes 
transduced with Neurog2ERT2 (red), Cre (green) in the absence (A) or 
presence of (OHT) according to the scheme in Figure 7 (A,B early deletion; 
C,D delayed deletion). Scale bar: 100µm. 
(E) Histogram depicting the proportion of Ascl1-regulated genes common to a 
specific time point analysed in the present study and genes regulated in	  
(Wapinski et al., 2013), compared to genes regulated at a specific time point. 
(F) Venn diagram showing genes regulated by Ascl1ERT2 in our analysis at 
any time and Ascl1 in Wapinski et al., 2013 (see Table S7 for gene list). 
(G) GO term analysis (Biological Processes) performed on the common 
genes at any time (212).	  
  
Supplemental Table legends 
 
Table S1, related to Figure 1. Overview of regulated genes upon 
Neurog2ERT2 induction. 
 
Table S2, related to Figure 1. Gene Ontology (GO) terms associated with 
genes regulated by Neurog2ERT2 after 4 hours of OHT treatment. Analysis 
was performed using DAVID analysis tool. Cut off pValue<0.05. 
 
Table S3, related to Figure 1. Overview of regulated genes upon Ascl1ERT2 
induction. 
 
Table S4, related to Figure 1. GO terms associated with genes regulated by 
Ascl1ERT2 after 4 hours of OHT treatment. Analysis was performed using 
DAVID analysis tool. Cut off pValue<0.05. 
 
Table S5, related to Figure 1. GO terms associated with genes regulated by 
both Neurog2ERT2 and Ascl1ERT2 after 24 hours of OHT treatment. Analysis 
was performed using DAVID analysis tool. Cut off pValue<0.05. 
 
Table S6, related to Figure 1. Overview of probesets regulated by 
Neurog2ERT2 and Ascl1ERT2 after 24 of OHT treatment. Pan-neuronal 
genes are indicated in red, genes associated with neurons with some regional 
differences in orange, or genes not directly associated with neuronal 
expression in black. 
 
Table S7, related to Figure 7. Overview of genes commonly regulated by 
Ascl1ERT2 after OHT at any time and genes regulated by Ascl1 in Wapinski 
et al. 2013. Genes in red are associated with nervous system expression, in 
blue genes associated with neuronal expression, and in black genes not 
directly related to neuronal expression. 
Table S5 
Overview of GO terms associated with genes regulated by both 
Neurog2ERT2 and Ascl1ERT2 after 24 hours of OHT treatment, related to 
Figure 1 	  
Category GO number Term PValue 
Fold 
Enrichment Genes 
SP_PIR_KEYWORDS  neurogenesis 4,29E-04 13,77623457 SEMA5A, HES5, SOX11, NEUROD4, SLIT1 
SP_PIR_KEYWORDS  differentiation 8,71E-04 6,037584541 
SEMA5A, HES5, SOX11, 
NEUROD4, HES6, 
CBFA2T3, SLIT1 
GOTERM_MF_FAT GO:0005509 GO:0005509~calcium ion binding 0,004706859 3,615782313 
SMOC2, NPTX1, CADM3, 
TESC, LRP8, SYT7, 
SLIT1, CALM1 
SP_PIR_KEYWORDS  calcium 0,008647342 3,799300806 
SMOC2, NPTX1, CADM3, 
TESC, LRP8, SYT7, 
CALM1 
SP_PIR_KEYWORDS  developmental protein 0,014192435 3,411902812 
SEMA5A, HES5, SOX11, 
NEUROD4, HES6, 
PROX1, SLIT1 
SP_PIR_KEYWORDS  methylation 0,017070488 7,181096028 GNG4, RASD1, RASD2, CALM1 
GOTERM_BP_FAT GO:0030182 GO:0030182~neuron differentiation 0,020559345 4,602045655 
SEMA5A, HES5, 
NEUROD4, SLIT1, 
TUBB3 
GOTERM_CC_FAT GO:0030054 GO:0030054~cell junction 0,022229501 4,434042553 
CADM3, LIMA1, 
9030425E11RIK, SYT7, 
HOMER2 
GOTERM_MF_FAT GO:0030528 GO:0030528~transcription regulator activity 0,030442265 2,518455342 
MYCL1, HES5, RCOR2, 
SOX11, NEUROD4, 
HES6, CBFA2T3, PROX1 
GOTERM_MF_FAT GO:0003700 GO:0003700~transcription factor activity 0,045757161 2,935493373 
MYCL1, RCOR2, SOX11, 
HES6, CBFA2T3, PROX1 
SP_PIR_KEYWORDS  prenylation 0,049635458 8,208735632 GNG4, RASD1, RASD2 	  
	  	  
Supplementary Experimental Procedures 
 
Cell Culture 
Astrocytes were expanded in uncoated plastic flasks, and, after one week 
harvested using trypsin/EDTA (Gibco) and plated onto poly-D-lysine (Sigma-
Aldrich) coated glass coverslips in 24-well plates (BD Biosciences) at a 
density of 50,000 cells per well or in uncoated 3 cm dishes (Nunc) at a density 
of 100,000 cells per dish in fresh and complete astrocyte medium 
(DMEM/F12, FBS 10%, B27, EGF 10ng/ml and FGF2 10ng/ml, 
penicillin/streptomycin). 'HSHQGLQJRQ the experiment, cells were either 
infected with retroviral particles 4-12 hours after plating or transfected with 
plasmids 24 hours after seeding; one day later, medium was replaced with 
differentiation medium (DMEM/F12 medium enriched with GlutaMAX (Gibco), 
penicillin/streptomycin and B27 supplement (Gibco)) to allow neuronal 
differentiation.  
Mouse embryo fibroblasts were grown in complete medium (DMEM, FBS 
10%, penicillin/streptomycin). After 3 to 4 passages, cells were harvested 
using trypsin/EDTA (Gibco) and plated onto poly-D-lysine (Sigma-Aldrich) 
coated glass coverslips in 24-well plates (BD Biosciences) at a density of 
25,000 cells per well in complete medium, and, after 4-12 hours, transduced 
with retroviruses. 24-36 hours later, complete medium was removed and 
differentiation medium was added. To improve survival, cells were treated with 
Forskolin (Sigma) and Dorsomorphin (Sigma) as described	  (Liu et al., 2013). 
Human astrocytes were expanded in Astromedium (ScienCell) and plated 
onto poly-L-lysine (2µg/ml) at a density of 50,000 cells/well in 24-well plates 
BD Biosciences). Cells were transduced with retroviruses 4-12 hours after 
plating and, one day later, the medium was replaced with differentiation 
medium. At 8 DPI, cells were fixed and analyzed by immunostaining. Cortical 
neurons were isolated from E14.5 embryos as previously described (Heins et 
al., 2002), and 40,000 cells were plated onto reprogrammed cultures.  
 
 
	  	  
Cloning procedures 
Atoh8 cDNA, kindly provided by Prof. R. Kageyama, was excised from pCLIG-
Atoh8 (Inoue et al., 2001), cloned into pENTRY1A (Life Technology) and, 
then, recombined with the retroviral plasmid pCAG-(Dest)-ires-GFP; Prox1 
cDNA, a gift of Dr. P.K. Politis (Kaltezioti et al., 2010), was excised from 
pEGFP-Prox1, cloned into pENTRY4 and subsequently recombined with the 
retroviral plasmid pCAG-(Dest)-ires-GFP ; Insm1 cDNA, from Prof. W. Huttner 
(Farkas et al., 2008) was excised from pTOPO-Insm1, cloned into pENTRY4 
and subsequently recombined with the retroviral plasmid pCAG-(Dest)-ires-
GFP; Hes6, purchased from OpenBiosystems (ThermoScientific), was 
recombined from pCMVSPORT-Hes6 into pDONR221 (Life Technologies) 
after removing the 3’UTR, and subsequently recombined with the retroviral 
plasmid pCAG-(Dest)-ires-GFP; NeuroD4 coding sequence, purchased from 
OpenBiosystems (ThermoScientific), was excised from pCMVSPORT-
NeuroD4, cloned into pENTR1A and recombined with the retroviral plasmid 
pCAG-(Dest)-ires-Dsred; Sox4 and Sox11 are gift from Prof. D. Chichung Lie 
(Mu et al., 2012), Trnp1 (Stahl et al., 2013). 
 
Micro-Chromatin immunoprecipitation (µChIP) and qPCR 
Around 100,000 cells per sample were fixed sequentially with di(N-succimidyl) 
glutarate and 1% formaldehyde in phosphate-buffered saline, then lysed  in 
100µl of SDS lysis buffer (0.5% SDS, 10mM EDTA, 50mM Tris-HCl pH8.0) 
supplemented with protease inhibitor cocktail (Roche), sonicated for 10 min, 
and diluted 5 times in IP buffer (0.2M HEPES pH8.0, 2M NaCl, 0.02M EDTA, 
0.1% Na-DOC, 1% Triton X-100, 1mg/ml BSA, protease inhibitor cocktail). 
Immunoprecipitations (for antibodies and dilutions see Supplementary 
Experimental procedures) were followed by 5X washing with modified RIPA 
buffer (50mM HEPES pH7.6, 1mM EDTA, 1% NP-40, 1% Na-DOC, 0.5M LiCl) 
5X and with Tris-EDTA buffer (10mM Tris-HCl pH8, 1mM EDTA) 1X and 
elution with 50 µl of IP elution buffer (50mM NaHCO3, 1% SDS) twice with 
vortexing for 15 min which were then combined to a clean tube to reverse 
cross-linking with 0.45M NaCl at 95°C for 15 min. Samples were treated with 
	  	  
proteinase K and purified using QIAquick MINelute column (Qiagen). 
Quantities of immunoprecipitated DNA were calculated by comparison with a 
standard curve generated by serial dilutions of input DNA using a 7500 Real-
Time PCR System (Applied Biosystems) and a SYBR green-based kit for 
quantitative PCR (iQ Supermix, Bio-Rad). The data were plotted as means of 
at least three independent ChIP assays and two independent amplifications. 
Antibodies and dilutions used for micro-Chromatin immunoprecipitation: rabbit 
anti-H3K4me3 (0.25 µg per ChIP sample; Millipore, 07-473), mouse anti-
H3K27me3 (0.25 µg per ChIP sample; Abcam, ab6002), mouse anti-
H4K20me3 (0.75 µg per ChIP sample; ActiveMotif, clone 6F8-D9), mouse 
anti-5’mC (0.4 µg per ChIP sample; Abcam, ab10805), rabbit anti-5’hmC (0.4 
µg per ChIP sample; ActiveMotif, 39791), rabbit anti-REST (0.75 µg per ChIP 
sample; Millipore, 07-579) or rabbit anti-HA (0.5 µg per ChIP sample; Abcam, 
ab9110). 
Below the list of primers used for ChIP experiments: 
Gene Name Primer forward Primer Reverse 
Atoh8_enh GAGCCAGCCAAAGTGCTAAC GGACACAGCCAGATGGTCTT 
Cnpy3 CTGGGTAACCACGGCAAC TCCTCTCATTGGCTATAAAGCAG 
Dll1 ORF GTCTCAGGACCTTCACAGTAG GAGCAACCTTCTCCGTAGTAG 
Insm1_intron	   GTGTCCGCTGAGTCCTTCC AGAACGCAGTGCCCATCTT 
Neurod1_prom	   GAACCACGTGACCTGCCTAT GTCCGCGGAGTCTCTAACTG 
Neurod1_REST TAACTGATTGCACCAGCCCTTCCT ACTCGGTGGATGGTTCGTGTTT
GA 
Neurod4_prom2 AAAAGGAGACCAGACCAGCA GGGTGGGGTGTAACAGATTG 
Neurod4_enh TACTGTGGGGGTGGGAGTAG CTAGGGCAAGCTAGGGAAGA 
Neurod4_REST CCCGCGAGTAGTTCTTTCAG CTACCCTGTGGGCAACATCT 
Prox1_prom CCAGGACGCAGGTCTTTTT TACTTTTCCGAGCCTTCCTC 
Sox11_prom TTCAAAAGAAATCCGCGAGT ATCTGCACTGGGGTTCAGTC 
Trnp1_enh CCATACCCACAATCCCTCTG GCCAAAGGACCAGAGTTGTG 
 
Transfection of mouse postnatal astroglia cultures 
For transfection DNA-liposome complexes were prepared in Optimem 
medium (Invitrogen) using the retroviral plasmids previously described and 
Lipofectamine 2000 (L2K, Invitrogen). Astrocyte cultures were exposed to 
DNA-liposome complexes at a concentration of 0.6 µg DNA with 0,75µl L2K 
per 400 µl of OptiMEM medium for 4 hours; then the transfection medium was 
replaced by fresh astrocyte medium and, one day later, the medium was 
changed with the differentiation medium. 
	  	  
 
Viral particle production 
Viral vectors were produced with a vesicular stomatitis virus pseudotype at 
titers of 108-11 as determined on HEK cells, and cells were infected about 12 
hours after splitting as described above (Heinrich et al., 2011). Cells were 
allowed to differentiate accordingly to the experiment performed. 
 
MicroRNA generation, validation and subcloning 
Gene specific MicroRNAs were designed using the Invitrogen miRNA 
Designer Center 
(https://rnaidesigner.lifetechnologies.com/rnaiexpress/setOption.do?designOp
tion=mirna) and cloned in pCDNA6.2eGFP according to manufacturer’s 
instructions. To test microRNA knock-down efficiency, HEK cells were 
transfected using Lipofectamine2000 (Invitrogen) with a vector encoding for 
the gene of interest and a DsRed-expressing control plasmid, and 
alternatively with a control plasmid (GFP), a scramble-eGFP-miRNA or gene-
specific-eGFP-miRNA. 48 hours later, cells were harvested, RNA was 
extracted using RNeasy MicroPlus Kit (Qiagen), quantified, retro-transcribed 
and analyzed by real time quantitative PCR as described previously. Gene 
expression was evaluated on the basis of cDNA content (human Gapdh 
expression, ΔΔCt method (Livak and Schmittgen, 2001) and normalized to the 
transfection efficiency (DsRed expression). Each sample was analyzed in 
triplicate. Primers used are listed below. 
 
Immunocytochemistry 
Cells were fixed in 4 % paraformaldehyde (PFA) in phosphate buffered saline 
(PBS) for 10 min at room temperature (RT), washed in PBS and pretreated in 
0.5% Triton X-100 in PBS for 30 min, followed by incubation in 3% BSA and 
0.5% Triton X-100 in PBS for 30 min. Primary antibodies were incubated on 
specimens at room temperature for 2 hours in 2% BSA, 0.5% Triton X-100 in 
PBS. The following primary antibodies were used: anti-Neurog2 (monoclonal 
anti-IgG2a, kindly provided by Dr. David Anderson, Howard Hughes Medical 
	  	  
Institute); anti-Flag (polyclonal, rabbit 1: 400, Sigma-Aldrich, F7425); anti-
Green Fluorescent Protein (polyclonal GFP, chicken, 1:400, Aves Labs, GFP-
1020); anti-Glial Fibrillary Acidic Protein (polyclonal GFAP, rabbit, 1:1000, 
DakoCytomation, Z0334; mouse monoclonal IgG1, 1:300, Sigma-Aldrich NB 
G3893); anti-GLAST (ACSA1, Milteny Biotec, 1:300, 130-095-822); Anti-
Aldh1l1 (monoclonal IgG1, 1:200, Millipore MAB N495);  anti-Red Fluorescent 
Protein (RFP, polyclonal rabbit, 1:1000, Rockland 600-401-379; rat 
monoclonal IgG2a 1:300, Chromotek); anti βIII-tubulin (mouse IgG2b, 1:500, 
Sigma, T8660);  anti MAP2 (polyclonal rabbit, 1:300, Miltenyi Biotec, AB 5622; 
mouse monoclonal IgG1, 1:300, Millipore, MAB 378); anti-vGlut1 (polyclonal 
rabbit, 1:300, Synaptic Systems, 135302); anti-vGAT (polyclonal guine pig, 
1:500, Synaptic Systems, 131004); anti-LeX (monoclonal mouse, Santa Cruz, 
sc-21702), anti-pSMAD1-5 (polyclonal rabbit, 41D10, Cell Signaling), anti-
nuclei (monoclonal mouse MAB1281, Chemicon). After washing in PBS, cells 
were incubated with appropriate species- or subclass-specific secondary 
antibodies conjugated to CyTM2, CyTM3, CyTM5 (1:500, Jackson 
ImmunoResearch), Alexa Fluor 488 (1:500, Invitrogen), FITC (fluorescein 
isothiocyanate, 1:500, Jackson ImmunoResearch), TRITC (tetramethyl 
rhodamine isothiocyanate, 1:500, Jackson ImmunoResearch) or biotin (1:500, 
Jackson ImmunoResearch or Vector Laboratories) for 2h in the dark at room 
temperature, followed by extensive washing in PBS. Following treatment with 
secondary antibodies conjugated to biotin, cells were subsequently incubated 
for 2h at room temperature with Alexa Fluor 405 streptavidin (1:500, 
Invitrogen), or stained with DAPI, then mounted with Aqua Poly/Mount 
(Polysciences, Warrington, PA). 
 
Microarray Analysis 
Total RNA, isolated with the RNeasy Micro Plus Kit, was analyzed with The 
Agilent 2100 Bioanalyzer and only high quality RNA (RIN>7) was used for 
microarray analysis. Total RNA (120 ng) was amplified using the one-cycle 
MessageAmp Premier labeling kit (Ambion). 10 µg of amplified aRNA were 
hybridized on Affymetrix Mouse Genome 430 2.0 arrays containing about 
	  	  
45,000 probe sets. Staining and scanning were done according to the 
Affymetrix expression protocol Expression console (v.1.2, Affymetrix) was 
used for quality control and to obtain annotated normalized RMA data 
(standard settings including quantile normalisation). Statistical analysis of the 
microarrays was performed by utilizing the statistical programming 
environment R (C., 2005) implemented in CARMAweb (Rainer et al., 2006). 
Genewise testing for differential expression was done employing the paired 
limma t-test. p-values<0.01 were used to define sets of regulated genes, 
which were further filtered for fold-changes>1.2x and average expression in 
one group>10.  Heatmaps were generated with CARMAweb. 
Below the list of primers used for the  Real Time qPCR: 
Gene Name Accession number Primer forward Primer reverse Probe # Ampl. Length 
Atoh8 NM_153778.3 tcagcttctccgagtgtgtg tagcctgtggcaggtcact 29 91 
Atoh8-Cod NM_153778.3 caaagccctgcagcagac ggagtagcacggcacctg 73 112 
Cnr1 NM_007726.3 gggcaaatttccttgtagca ggctcaacgtgactgagaaa 79 130 
Dll3 NM_007866.2 ctgcctgatggcctcgta gctgctctctccaggtttca 7 85 
Dlx2 NM_010054.2 gcctcacccaaactcaggt aggcacaaggaggagaagc 1 126 
Gapdh 
(human) NM_002046 agccacatcgctcagacac gcccaatacgaccaaatcc 66 60 
Gapdh 
(mouse) BC083065 ttcaccaccatggagaagg cacacccatcacaaacatgg 29 102 
Hes6 NM_019479.3 acggatcaacgagagtcttca ttctctagcttggcctgcac 66 72 
Insm1 NM_016889.3 ggtttgctctgcctaccaat tcacccaaaacaacccgta 108 62 
Lmo1 NM_057173 ccggcgtgactacctgag aagctgggatcagcttgc 27 71 
NeuroD1 NM_010894.2 cgcagaaggcaaggtgtc tttggtcatgtttccacttcc 1 90 
NeuroD4 NM_007501.4  actactcgcgggagctgac ccatccaggattgtgtgttg 22 104 
NeuroD4-cod NM_007501.4 aactggggcctcaatctacc agtcacaaattgaagatttttcctc 80 60 
Phf6 NM_027642.1 ggaaattaaaagaggcacaaagc gttttcacatcacagccaatg 1 78 
Prox1 NM_008937.2 cgacatctcaccttattcagga ttgcctttttcaagtgattgg 4 68 
pvalb NM_013645 ggcaagattggggttgaag agcagtcagcgccacttag 83 63 
Sfrp1 NM_013834.3 atgtgctccagaagcagacc gtcagagcagccaacatgc 80 60 
Sox11 NM_009234.6 gagctgagcgagatgatcg gaacaccaggtcggagaagt 20 60 
Trnp1 NM_001081156.2 agtcagctgggggtccat atgcagaagtcagtccagacc 110 87 
Trnp1-Cod NM_001081156.2 ctgcaccgagtcttcttgg gcgcacccttcttgagac 71 133 
 
 
Microscopy and quantification 
Immunostainings were analyzed with a LSM710 laser-scanning confocal or 
Axio Observer Z1 epifluorescence microscope (Carl Zeiss). Digital images 
were captured using the ZEN2009-2011 software (Carl Zeiss). Retroviral 
vector-transduced cells or transfected cells were quantified from more than 30 
randomly chosen 20x fields in at least 3 independent experiments. Branch 
quantification was performed using the plug-in “Simple Neurite Tracer” 
(Longair et al., 2011) for the image software in Fiji (Schindelin et al., 2012). 
 
	  	  
Electrophysiology 
For electrophysiological recordings, coverslips with reprogrammed cells were 
transferred to an organ bath mounted on the stage of an upright microscope 
(Axioscope FS, Zeiss, Göttingen, Germany). Cells on coverslips were 
perfused with a bathing solution consisting of (in mM): NaCl 150, KCl 3, CaCl2 
3, MgCl2 2, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 10, 
and D-glucose 10. The pH of the solution was adjusted to 7.4 (NaOH) and its 
osmolarity ranged between 309 to 313 mOsmol. The perfusion rate with 
bathing solution (see Main Materials and Methods) was set to 1.4 ml / min and 
recordings were performed at room temperature (23 – 24°C). In order to 
visualize the cultured cells, the microscope was equipped with differential 
interference contrast (DIC) optics and with epifluorescence optics for green 
and red fluorescence (filter sets: Zeiss BP450-490, LP520, Zeiss BP546/12, 
lP590). Images were taken and displayed using a software-operated CCD 
microscope camera (ORCA R, Hamamatsu, Herrsching, Germany). 
The recorded signals were amplified (x10 or x20), filtered at 10 or 20 kHz 
(current clamp) and 3 kHz (voltage clamp), digitized at a sampling rate of 10 
or 20 kHz and stored on a computer for off-line analysis. Data acquisition and 
generation of command pulses was done by means of a CED 1401 Power 3 
system in conjunction with Signal6 data acquisition software (Cambridge 
electronic design, Cambridge, England). Data analysis was performed using 
IGOR Pro 6 (WaveMetrics, Lake Oswego, USA) together with the NeuroMatic 
IGOR plugin (www.neuromatic.thinkrandom.com). The action potential 
discharge pattern of the cells was investigated by injections of depolarizing 
current pulses (1 – 2 s), the amplitudes of which were raised in steps (5 or 10 
pA) from 0 – 200 pA at a frequency of 0.1 Hz. 
The electrodes for whole cell patch-clamp recordings were fabricated from 
borosilicate glass capillaries (OD: 1.5 mm, ID: 0.86 mm, Hugo Sachs 
Elektronik-Harvard Apparatus, March-Hugstetten, Germany) and filled with a 
solution composed of (in mM): potassium gluconate 135, KCl 4, NaCl 2, 
ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) 0.2, 
HEPES (potassium salt) 10, adenosine-triphosphate (magnesium salt, 
	  	  
ATP[Mg]) 4, sodium guanosine-triphosphate (NaGTP) 0.5, and 
phosphocreatine 10 (pH: 7.25 – 7.30, osmolarity: 288 – 291 mOsmol). The 
electrodes (resistance: 5 – 6 MW) were connected to the headstage of a npi 
ELC-03XS amplifier (npi, Tamm, Germany). The series resistance determined 
after establishment of the whole cell recording mode (9 – 17 MW) was 
compensated by 70 – 85%. Microscope images were corrected for contrast 
and brightness with Photoshop CS3 (Adobe Software Systems, Ireland). 
By using the motorized microscope stage, each coverslip was scanned 
systematically and reprogrammed cells were identified by their simultaneous 
green and red fluorescence. Following membrane rupture, the cells were 
voltage-clamped to a holding potential of -60 mV and kept under this condition 
until stabilization of the holding current was achieved (3 – 5 min). Then the 
amplifier was switched to the current-clamp mode and the resting membrane 
potential was registered. Determination of the input resistance RN was 
performed either by measurement of the amplitude of a voltage deviation 
induced by a small hyperpolarizing current pulse (1 s, 5 – 10 pA) or by 
determining the slope of the current-voltage-curve (IV-curve). The somatic 
membrane time constant t was derived by fitting a dual exponential function to 
the voltage relaxation following cessation of a small hyperpolarizing current 
pulse and the total membrane capacity CN was estimated using a method 
described by (Zemankovics et al., 2010). The ability of the cells to generate 
action potentials was tested by injecting depolarizing current pulses (50 ms) 
with increasing current strengths (DI: 5 or 10 pA) or by depolarizing current 
ramps (50 ms) from 0 – 100 pA. The amplitudes of the action potentials 
(spikes) were measured as the difference between the resting membrane 
potential and the spike maximum, the spike duration was determined at half-
maximum amplitude and the spike threshold was derived from a phase-plane 
plot (Bean, 2007). The action potential discharge pattern of the cells was 
investigated by injections of depolarizing current pulses (1 – 2 s), the 
amplitudes of which were raised in steps (5 or 10 pA) from 0 – 200 pA at a 
frequency of 0.1 Hz. 
All chemicals and drugs were obtained from Sigma-Aldrich (Munich, 
	  	  
Germany) and Biotrend (Cologne, Germany), respectively. The GABAA-
receptor antagonist bicuculline (methiodide, 10µM), the AMPA receptor 
antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione 
(NBQX, 5-10µM), the NMDA receptor antagonist D-2-amino-5-
phosphonopentanoate (D-AP5), and the sodium channel blocker tetrodotoxin 
(TTX) were added to the bathing solution. Data are given as mean and 
standard deviation (SD). Statistical comparison of 2 samples was performed 
by using a two-tailed unpaired t-test. Comparisons of 3 or more samples were 
done by means of a one-way analysis of variance (ANOVA with Bonferroni 
post-tests). 
 
Statistics 
Statistical analyses were performed with GraphPrism 4 software by using 1-
way-ANOVA Bonferroni post-test or two-tailed unpaired t-test as indicated in 
the figures. 
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